ADMA Stock Balance Sheets

ADMA Biologics Quarterly Balance Sheets Chart

Quarterly

Annual

Goodwill

Account Receivables

Cash and Cash Eq

Account Payables

Inventory

ADMA Biologics Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-03-31	2008-12-31

assets
current assets:
cash and cash equivalents	90,285,000	71,625,000	103,147,000	86,707,000	88,244,000	45,325,000	51,352,000	74,156,765	62,512,889	69,204,163	86,521,542	34,906,020	52,415,053	69,504,946	51,089,118	34,410,570	42,408,958	61,965,709	55,921,152	59,675,045	75,781,122	101,235,699	26,752,135	48,006,152	73,615,909	16,534,278	22,754,852	42,367,489	55,153,975	26,119,837	43,107,574	13,601,391	25,574,009	8,542,928	9,914,867	7,905,975	12,549,173	8,925,132	10,440,959	9,177,767	7,821,841	16,564,190	17,199,030	13,951,525	17,869,031	26,517,959	26,149,477	5,380,043	7,653,479	10,320,517	12,535,672	10,720,397	12,887,788	14,239,828	5,909	8,512	16,192	3,100	3,619	12,012	2,934	6,844	9,270	10,108	8,028
accounts receivable	109,726,000	99,412,000	49,999,000	50,140,000	30,113,000	49,621,000	27,421,000	31,318,680	36,731,612	26,518,495	15,505,048	20,902,385	18,883,847	25,629,625	28,576,857	20,392,621	23,544,594	15,362,030	13,237,290	6,334,536	6,514,165	7,107,834	3,469,919	7,315,481	5,086,663	1,310,404	1,392,441	4,126,794	3,797,194	3,657,602	3,880,154	1,499,809	2,292,274	839,938	1,018,027	1,327,531	826,715	943,950	924,468	1,200,615	522,499	351,443	383,961	562,171	803,513	484,423		335,091	236,918	326,327	39,112	61,897	220,096
inventories	191,464,000	172,188,000	170,235,000	171,801,000	179,810,000	177,732,000	172,906,000	163,116,105	161,780,063	163,984,873	163,280,047	162,913,633	146,075,459	139,146,311	124,724,091	114,122,873	99,699,743	94,146,200	81,535,599	69,752,528	56,001,348	52,288,803	53,064,734	40,285,339	23,589,750	18,439,912	18,616,169	13,877,434	12,246,968	12,438,802	12,628,181	13,418,971	13,150,733	5,308,492	5,020,146	4,617,734	4,209,326	4,049,239	3,445,773	2,830,814	2,452,896	1,940,934	1,708,763	1,452,556	1,112,601	984,493	1,669,058	1,205,073	915,156	1,007,267	1,265,593	1,009,687	1,203,041	1,175,288
prepaid expenses and other current assets	8,088,000	8,589,000	8,029,000	9,545,000	5,524,000	3,741,000	5,334,000	5,107,455	5,218,735	4,378,681	5,095,146	5,372,484	5,399,928	5,519,301	4,339,245	5,859,046	5,701,863	5,802,608	3,046,466	3,786,421	4,693,427	4,855,344	2,533,593	1,716,337	1,596,671	2,049,552	1,766,163	2,131,035	2,431,366	2,703,214	2,050,740	2,078,509	2,408,459
total current assets	399,563,000	351,814,000	331,410,000	318,193,000	303,691,000	276,419,000	257,013,000	273,699,005	266,243,299	264,086,212	270,401,783	224,094,522	222,774,287	239,800,183	208,729,311	174,785,110	171,355,158	177,276,547	153,740,507	139,548,530	142,990,062	165,487,680	85,820,381	97,323,309	103,888,993	38,334,146	44,529,625	62,502,752	73,629,503	46,419,455	63,166,649	31,444,069	44,270,864	15,683,204	21,657,138	25,359,589	29,494,236	17,358,209	21,290,404	25,240,341	27,126,916	30,982,138	24,088,015	22,571,543	26,493,609	30,787,513	31,052,449	7,143,625	9,172,513	12,305,553	13,948,138	11,981,577	14,619,089	15,843,577
property and equipment	57,501,000	57,710,000	54,707,000	53,694,000	54,326,000	55,317,000	53,835,000	54,814,607	56,305,620	57,370,783	58,261,481	56,946,090	54,951,267	53,220,480	50,935,074	48,393,723	46,486,980	44,175,613	41,593,090	39,622,510	37,373,366	35,060,795	31,741,317	30,712,915	29,444,489	29,694,764	30,115,730	30,362,629	30,337,285	30,615,530	30,466,858	29,755,541	28,626,668																			803,709	825,236
intangible assets	527,000	452,000	460,000	485,000	479,000	321,000	499,000	476,902	655,740	834,577	1,013,415	1,192,254	1,371,092	1,549,930	1,728,768	1,907,607	2,086,445	2,265,283	2,444,121	2,622,959	2,801,797	2,980,636	3,159,474	3,370,708	3,581,943	3,793,177	4,004,412	4,215,646	4,426,881	4,638,115	4,849,350	5,737,175	6,011,003
goodwill	3,530,000	3,530,000	3,530,000	3,530,000	3,530,000	3,530,000	3,530,000	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509	3,529,509
deferred tax assets	79,235,000	80,855,000	84,280,000
right-to-use assets	8,961,000	8,020,000		8,897,000	9,152,000	9,397,000	9,635,000	9,753,725
deposits and other assets	9,063,000	8,188,000	5,657,000	5,819,000	5,221,000	5,891,000	4,670,000	6,722,817	6,289,048	4,718,761	4,770,246	4,459,322	3,755,938	2,825,748	4,067,404	3,333,514	2,526,660	2,222,781	2,106,976	1,869,548	4,846,834	3,465,207	2,840,044	2,843,332	2,829,186	2,768,374	1,543,737	530,173	533,422	539,572	510,057	750,693
total assets	558,380,000	510,569,000	488,678,000	390,618,000	376,399,000	350,875,000	329,182,000	348,996,565	343,027,042	340,787,542	348,461,881	300,557,570	296,932,329	308,032,492	276,252,724	238,640,406	232,813,792	235,667,028	207,673,394	189,976,043	191,541,568	210,523,827	127,090,725	137,779,773	143,274,120	78,119,970	88,876,521	106,345,100	117,751,992	91,137,625	108,018,833	72,813,480	84,639,253	17,594,918	23,685,085	27,495,386	31,741,989	19,684,920	23,714,517	27,824,030	29,799,772	33,927,680	27,227,497	25,287,215	27,882,931	31,951,324	31,979,943	8,701,866	10,690,103	13,817,307	15,555,419	13,224,826	15,883,865	17,008,314	5,909	8,512	16,192	3,100	3,619	12,012	2,934	6,844	9,270	10,108	8,028
liabilities and stockholders' equity
current liabilities:
accounts payable	29,769,000	20,607,000	20,219,000	16,020,000	14,179,000	17,186,000	15,660,000	10,851,446	12,084,529	12,956,486	13,229,390	25,197,806	11,388,048	14,115,135	12,429,409	17,282,841	6,167,465	12,152,852	11,073,708	7,979,772	6,909,659	9,152,239	9,174,591	8,959,903	6,788,144	5,479,791	5,900,394	5,267,683	3,101,079	5,718,121	5,920,873	9,156,341	4,672,316	3,904,445	2,564,681	2,777,221	3,317,052	2,468,470	2,087,855	2,184,686	1,647,556	1,778,953	1,779,197	2,444,904	2,339,722	2,763,872	2,709,489	1,482,643	1,158,826	1,379,011	1,058,671	890,762	790,869	508,852
accrued expenses and other current liabilities	43,902,000	31,560,000	33,962,000	27,535,000	27,726,000	33,691,000	32,919,000	29,863,726	28,745,598	22,672,464	24,989,349	18,378,932	15,961,070	16,654,540	17,214,988	14,410,329	11,490,239	8,592,142	8,365,143	8,074,989	5,616,666	4,419,043	4,481,395	4,762,771	2,974,476	2,505,996	3,551,835	4,453,027	3,644,181
current portion of deferred revenue	143,000	143,000	143,000	143,000	1,130,000	1,118,000	182,000	142,834	142,834	142,834	142,834	142,834	142,834	142,834	142,834	142,834	142,834	142,834	142,834	142,834	142,834	142,834	142,834	1,197,910	142,834	142,834	142,834	142,834	142,834	142,834	142,834	145,154	145,154	145,154	145,154	145,154	145,154	145,154	145,154	149,326	75,556	75,555	75,556	75,556	75,556	75,556	75,556	75,556	69,259
current portion of lease obligations	1,127,000	1,188,000	1,218,000	1,193,000	1,142,000	1,093,000	1,045,000	982,891	979,536	956,045	905,369	720,755	579,661	654,003	591,084	501,239	385,858	317,910	365,682	275,988	210,870	193,987	229,073	229,516	223,114	209,506
total current liabilities	74,941,000	53,498,000	55,542,000	44,891,000	44,177,000	53,088,000	49,806,000	41,840,897	41,952,497	36,727,829	39,266,942	44,440,327	28,071,613	31,566,512	30,378,315	32,337,243	18,186,396	21,205,738	19,947,367	16,473,583	12,880,029	13,908,103	14,027,893	15,150,100	10,128,568	8,338,127	9,625,046	9,892,987	6,917,086	9,442,837	9,440,183	13,338,866	15,645,011	12,957,920	11,222,861	9,207,805	5,082,539	4,291,028	4,216,532	4,298,235	3,200,041	3,786,811	4,197,897	4,118,670	3,796,785	4,303,402	3,657,846	2,517,119	2,028,744	2,100,801	1,817,319	1,403,533	1,005,640	1,027,057	9,809	9,818	5,818	4,818	8,608	12,358	6,708	5,808	9,908	6,858	7,458
senior notes payable, net of discount	73,397,000	72,527,000	72,337,000	101,326,000	131,074,000	130,847,000	130,594,000	142,025,542	140,312,070	144,300,930	142,833,063	141,365,706	139,810,931	138,423,052	94,866,239	94,363,008	93,877,017	93,412,660	92,968,866	82,108,633	81,648,187	81,212,090	68,291,163	67,839,162	67,468,637
deferred revenue, net of current portion	1,476,000	1,512,000	1,547,000	1,583,000	1,619,000	1,654,000	1,690,000	1,725,906	1,761,614	1,797,323	1,833,031	1,868,739	1,904,448	1,940,156	1,975,865	2,011,573	2,047,281	2,082,990	2,118,698	2,154,407	2,190,115	2,225,823	2,261,532	2,297,240	2,332,949	2,368,657	2,404,365	2,440,074	2,475,782	2,511,491	2,547,199	2,582,908	2,618,616	2,654,325	2,690,033
end of term fee	938,000	1,313,000	1,313,000	1,688,000	1,688,000	1,688,000	1,688,000	1,567,139	1,567,139	1,500,000	1,500,000	1,500,000	1,500,000	1,500,000
lease obligations, net of current portion	9,301,000	8,298,000	8,561,000	8,865,000	9,182,000	9,487,000	9,779,000	9,965,088	10,221,914	10,468,109	10,704,176	10,636,083	10,870,907	7,284,079	7,462,388	6,915,750	7,073,415	6,419,589	4,334,151	2,860,732	2,937,292	1,831,639	1,302,361	1,356,390	1,414,976	1,461,452
other non-current liabilities	2,000	2,000	360,000	375,000	390,000	405,000	419,000	434,647	449,513	338,731	350,454	362,179	373,903	385,628	397,351	232,665	36,151	41,965	54,886	67,808	80,730	93,652	106,574	119,496	132,418	145,340	260,734	277,692	347,898	309,353	105,996	118,318	93,937
total liabilities	160,055,000	137,150,000	139,660,000	158,728,000	188,130,000	197,169,000	193,976,000	197,559,219	196,264,747	195,132,922	196,487,666	200,173,034	182,531,802	181,099,427	135,080,158	135,860,239	121,220,260	123,162,942	119,423,968	118,600,089	114,662,113	114,188,144	100,897,576	101,661,701	96,368,259	68,081,016	69,106,083	69,138,886	65,992,922	68,112,226	67,686,076	59,820,972	56,957,264	28,353,266	28,142,347	27,647,526	27,825,853	23,054,235	22,893,543	22,909,788	20,280,264	20,497,212	21,218,847	16,042,268	15,580,355	16,047,637	10,406,584	9,437,622	8,962,133	7,416,664	6,131,673	1,617,786	1,228,134	1,257,958
commitments and contingencies
stockholders' equity
preferred stock, 0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, june 30, 2025: 239,383,545 issued and 238,567,308 outstanding; december 31, 2024: 236,620,545 issued and outstanding	24,000
treasury stock
additional paid-in capital	660,909,000	655,074,000	657,577,000	652,345,000	644,634,000	642,133,000	641,439,000	640,025,888	637,916,035	630,437,880	629,968,704	566,149,846	565,266,375	564,034,008	553,265,706	498,229,637	489,330,692	471,336,826	428,704,039	392,424,321	381,010,696	380,288,833	290,903,772	290,267,664	289,616,994	239,539,512	236,203,041	235,600,830	235,018,201	191,536,802	191,022,018	150,700,918	150,187,687	102,712,144	102,476,267	102,222,281	101,959,318	88,661,749	88,239,569	87,750,184	87,253,027	86,484,669	75,457,458	75,130,398	74,803,338	74,443,204	74,209,004	47,199,023	46,973,802	46,751,031	46,532,612	46,464,366	46,263,121	46,151,031	141,080	138,500	138,500	121,500	113,000	113,000	102,000	102,000	96,000	87,000	80,500
accumulated deficit			-308,583,000	-420,479,000	-456,388,000	-488,450,000	-506,256,000	-488,611,138	-491,176,193	-484,805,486	-478,016,671	-465,784,988	-450,885,484	-437,120,578	-412,112,721	-395,463,301	-377,750,347	-358,845,044	-340,465,103	-321,057,329	-304,139,876	-283,961,785	-264,716,555	-254,155,524	-242,717,065	-229,505,193	-216,437,238	-198,399,251	-183,263,766	-168,515,935	-150,693,793	-137,710,991	-122,508,276	-113,471,781	-106,934,818	-102,375,710	-98,044,471	-92,032,136	-87,419,667	-82,837,014	-77,734,590	-73,055,272	-69,449,737	-65,886,380	-62,501,691	-58,540,446	-52,636,574	-47,935,366	-45,246,419	-40,350,975	-37,109,328	-34,857,791	-31,612,044	-30,405,329
total stockholders' equity	398,325,000	373,419,000											114,400,527					112,504,086	88,249,426	71,375,954	76,879,455	96,335,683	26,193,149	36,118,072	46,905,861	10,038,954	19,770,438	37,206,214	51,759,070	23,025,399	40,332,757	12,992,508	27,681,989				3,916,136		820,974	4,914,242	9,519,508	13,430,468	6,008,650	9,244,947	12,302,576	15,903,687	21,573,359		1,727,970	6,400,643					-3,900		10,374	-1,718	-4,989
total liabilities and stockholders' equity	558,380,000	510,569,000											296,932,329					235,667,028	207,673,394	189,976,043	191,541,568	210,523,827	127,090,725	137,779,773	143,274,120	78,119,970	88,876,521	106,345,100	117,751,992	91,137,625	108,018,833	72,813,480	84,639,253				31,741,989		23,714,517	27,824,030	29,799,772	33,927,680	27,227,497	25,287,215	27,882,931	31,951,324	31,979,943		10,690,103	13,817,307					5,909	8,512	16,192	3,100	3,619	12,012
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 238,532,252 and 236,620,545 shares issued and outstanding at march 31, 2025 and december 31, 2024		24,000
right-of-use assets			8,634,000
liabilities and stockholders’ equity
stockholders’ equity
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 236,620,545 and 226,063,032 shares issued and outstanding at december 31, 2024 and december 31, 2023			24,000
total stockholders’ equity			349,018,000	231,890,000	188,269,000	153,706,000	135,206,000	151,437,346	146,762,295	145,654,620	151,974,215	100,384,536		126,933,065	141,172,566	102,780,167	111,593,532																																		9,423,746	11,607,040	14,655,731	15,750,356		-1,306				-346	-3,774	1,036		3,250	570
total liabilities and stockholders’ equity			488,678,000	390,618,000	376,399,000	350,875,000	329,182,000	348,996,565	343,027,042	340,787,542	348,461,881	300,557,570		308,032,492	276,252,724	238,640,406	232,813,792																																		15,555,419	13,224,826	15,883,865	17,008,314							2,934	6,844	9,270	10,108	8,028
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 236,378,607 and 226,063,032 shares issued and outstanding at september 30, 2024 and december 31, 2023				24,000
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 233,026,736 and 226,063,032 shares issued and outstanding at june 30, 2024 and december 31, 2023					23,000
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 231,769,765 and 226,063,032 shares issued and outstanding at march 31, 2024 and december 31, 2023						23,000
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 226,063,032 and 221,816,930 shares issued and outstanding							23,000
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 225,958,084 and 221,816,930 shares issued and outstanding								22,596
right to use assets									10,003,826	10,247,700	10,485,447	10,335,873	10,550,236	7,106,642	7,262,658	6,690,943	6,829,040	6,197,295	4,259,191	2,782,987
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 224,526,748 and 221,816,930 shares issued and outstanding									22,453
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 222,262,588 and 221,816,930 shares issued and outstanding										22,226
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 221,816,930 and 195,813,817 shares issued and outstanding											22,182
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 196,776,871 and 195,813,817 shares issued and outstanding												19,678
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 196,356,232 and 195,813,817 shares issued and outstanding													19,636
common stock - voting, 0.0001 par value, 300,000,000 shares authorized, 196,347,529 and 195,813,817 shares issued and outstanding														19,635
common stock - voting, 0.0001 par value, 300,000,000 and 150,000,000 shares authorized, 195,813,817 and 104,902,888 shares issued and outstanding															19,581
common stock - voting, 0.0001 par value, 300,000,000 and 150,000,000 shares authorized, 138,313,817 and 104,902,888 shares issued and outstanding																13,831
common stock - voting, 0.0001 par value, 300,000,000 and 150,000,000 shares authorized, 131,872,026 and 104,902,888 shares issued and outstanding																	13,187
common stock - voting, 0.0001 par value, 150,000,000 shares authorized, 123,044,981 and 104,902,888 shares issued and outstanding																		12,304
subordinated note payable, net of discount																				14,934,926	14,925,760	14,916,837	14,908,053	14,899,313	14,890,711
preferred stock, 0.0001 par value, 10,000,000 shares authorized,
no shares issued and outstanding
common stock - voting, 0.0001 par value, 150,000,000 shares authorized,
104,902,888 and 59,318,355 shares issued and outstanding																			10,490
common stock																				8,962	8,635																																		250	250	250	250	250	250	250	250	250	250	250
common stock - voting, 0.0001 par value, 150,000,000 shares authorized, 86,345,313 and 59,318,355 shares issued and outstanding																						8,635
assets to be transferred under purchase agreement																											1,153,508	1,204,391	1,295,392	1,395,444	1,496,410	1,596,493	1,698,755
restricted cash																														1,500,000	1,500,000																	452,004	452,004	452,004	452,004	426,963	426,963	336,963
end of term liability, notes payable																											2,760,000	2,760,000	2,760,000	2,760,000	2,760,000	1,790,000	1,790,000	1,790,000	1,790,000	1,790,000	1,790,000	1,432,000	1,432,000	1,432,000	1,432,000	132,500	132,500	132,500	132,500	132,500	132,500	132,500	132,500
obligation to transfer assets under purchase agreement																											12,621,844	12,621,844	12,621,844	12,621,844	12,621,844	12,621,844
common stock - voting, 0.0001 par value, 150,000,000 and 75,000,000 shares authorized,
59,318,355 and 46,353,068 shares issued and outstanding																							5,932
common stock - voting, 0.0001 par value, 150,000,000 and 75,000,000 shares
authorized, 59,318,355 and 46,353,068 shares issued and outstanding																								5,932
common stock - voting, 0.0001 par value, 75,000,000 shares
authorized, 59,317,806 and 46,353,068 shares issued and outstanding																									5,932
notes payable, net of discount																										40,885,103	26,440,830	26,153,543	25,878,081	25,616,653	25,368,458	14,534,340	9,360,708
note payable - related party, net of discount																										14,882,337	14,874,184	14,865,981	14,857,908	14,850,048	14,842,396	14,834,696	14,827,148
authorized, 46,353,068 shares issued and outstanding																										4,635
current portion of capital lease obligation																											29,983	29,443	28,992
capital lease obligation																											119,080	126,765	134,323
authorized, 46,353,068 and 36,725,499 shares issued and outstanding																											4,635
common stock - non-voting, 0.0001 par value, 8,591,160 shares
authorized, 0 and 8,591,160 shares issued and outstanding
authorized, 46,351,243 and 36,725,499 shares issued and outstanding																												4,635
authorized, 46,349,514 and 36,725,499 shares issued and outstanding																													4,635
accrued expenses																														3,581,882	3,318,478	3,860,121	4,143,812	2,224,719	2,385,356	1,824,798	1,604,500	1,661,922	1,968,384	1,949,419	1,462,561	1,803,434	2,223,639	1,511,010	1,225,999	1,349,931	823,550	911,130	753,143	676,667	747,079	502,594	204,594	508,254	9,809	9,818	5,818	4,818	8,608	12,358	6,708	5,808	9,908	6,858	7,458
other current liabilities																															57,998	177,250	17,062
authorized, 36,726,084 and 36,725,499 shares issued and outstanding																														3,673
authorized, 8,591,160 shares issued and outstanding																														859
short-term investments																																		245,000	5,390,184	11,026,691	11,270,963	2,694,978	6,368,177	11,764,361	15,930,353	11,512,214	4,652,675	6,319,629	6,313,578	2,203,040	2,935,184
current portion of notes payable																																	6,666,667
authorized, 36,725,499 and 12,886,741 shares issued and outstanding																															3,673
authorized, 8,591,160 and 0 shares issued and outstanding																															859	859	859
assets held for sale																																845,389	845,389
authorized, 17,202,244 and 12,886,741 shares issued and outstanding																																1,722
deposits																																	502,454	29,563	27,163	27,163	27,163	27,163	27,163	27,163	27,163	27,163	27,163	27,163	27,163	27,163	12,577	12,577	12,577	12,577	12,577	12,577	12,577	12,577
purchase price payable																																	12,621,844
authorized, 17,182,321 and 12,886,741 shares issued and outstanding																																	1,719
prepaid expenses																																		746,846	313,914	481,658	638,059	744,910	111,027	266,784	399,327	613,357	143,586	285,662	394,886	597,598	298,730	223,418	366,960	651,442	107,761	189,596	308,164	428,461
property and equipment at cost																																		1,882,151	2,000,784	2,108,634	2,220,590	2,295,994	2,396,950	2,518,638	2,627,693	2,737,762	2,840,698	2,381,200	1,038,927	828,948	765,299	811,398	849,917	801,757				815,197
other assets:
total other assets																																		29,563	27,163	27,163	27,163	30,717	27,163	65,051	45,163	207,780	298,784	334,472	350,395	334,863	162,195	746,843	667,673	709,997	827,984	439,540	439,540	349,540
liabilities and stockholders' deficiency
current portion of note payable																																		6,666,667	6,111,111	4,444,440
current portion of leasehold improvement loan																																		16,935	16,559	16,192	15,833	15,482	15,139	14,804	14,368	14,154	13,841	13,534	13,234	12,941	12,654	12,373	12,099	11,831	11,569	10,177	10,177	9,951
notes payable, net of debt discount																																		10,845,226	12,321,640	13,794,246	18,050,306	14,380,759	14,247,212	14,115,986	13,993,127	14,892,642	14,772,266	9,859,876	9,706,530	9,674,139	4,865,228	4,840,508	4,816,650	4,793,867
deferred rent liability																																		90,476	98,116	105,756	113,396	121,036	128,676	136,316	143,956	151,596	83,214	88,761	94,309	99,857	105,404	110,952	116,500	122,047	127,595	133,142	138,690	144,238
leasehold improvement loan, net of current portion																																		15,319	19,697
stockholders' deficiency
preferred stock 0.0001 par value 10,000,000 shares authorized,
and 0 shares issued and outstanding as of march 31, 2017
and december 31, 2016, respectively
common stock 0.0001 par value 75,000,000 shares
authorized, and 12,886,741 shares issued and outstanding
as of march 31, 2017 and december 31, 2016, respectively																																		1,289
total stockholders' deficiency																																		-10,758,348
total liabilities and stockholders' deficiency																																		17,594,918
revenues:
product revenue																																		2,593,163
license and other revenue																																		35,708
total revenues																																		2,628,871
operating expenses:
cost of product revenue																																		1,616,287
research and development																																		1,192,727
plasma centers																																		1,479,476
general and administrative																																		4,277,384
total operating expenses																																		8,565,874
income from operations																																		-5,937,003
other income:
interest income																																		18,568
interest expense																																		-618,528
other income,net																																		-599,960
net income																																		-6,536,963
net income per common share,
basic and diluted																																		-0.51
weighted-average shares
outstanding, basic and diluted																																		12,886,741
liabilities and stockholders' (deficiency) equity
stockholders' (deficiency) equity
authorized, and 12,886,741 and 10,713,087 shares issued
and outstanding as of december 31, 2016 and december 31, 2015,
respectively																																			1,289	1,289	1,289
total stockholders' (deficiency) equity																																			-4,457,262	-152,140		-3,369,315										-735,756
total liabilities and stockholders' (deficiency) equity																																			23,685,085	27,495,386												8,701,866
deferred revenue																																				2,725,742	2,761,450	2,797,158	2,832,867	2,887,082	1,467,037	1,485,926	1,504,815	1,523,704	1,542,592	1,561,481	1,580,370	1,599,259	1,624,444
leasehold improvement loan																																				23,977	28,162	32,254	36,256	40,169	44,103	47,737	51,395	54,973	58,471	61,890	65,236	68,507	71,705	74,832	77,890	81,111	83,804	86,663
and outstanding as of september 30, 2016 and december 31, 2015,
and outstanding as of june 30, 2016 and december 31, 2015,
deferred financing costs																																						3,554		37,888	18,000	180,617	271,621	307,309	323,232	307,700	149,618	282,262	203,092	245,416	363,403
authorized, and 10,713,087 shares issued
and outstanding																																						1,072					929	929	929
total liabilities and stockholders'
equity																																						19,684,920
accrued interest																																										114,715	105,664	73,666	142,274	101,102	36,597	35,417	35,417	33,292
warrant liability																																											476,760	263,784	249,168	214,368		168,777	171,590	192,617	229,345
authorized, and 10,713,087 and 9,291,823 shares issued
and outstanding as of december 31, 2015 and december 31,
2014, respectively																																							1,072	1,072	1,071	1,071
and outstanding as of september 30, 2015 and december, 31
authorized, and 10,705,573 and 9,291,823 shares issued
and outstanding as of june 30, 2015 and december 31,
and outstanding as of march 31, 2015, and december, 31
authorized, and 9,291,823 shares issued
and outstanding at march 31, 2014 and december 31, 2013																																														929
authorized, 9,291,823 and 5,871,002 shares issued
and outstanding at december 31, 2013 and 2012, respectively																																															929
common stock .0001 par value 75,000,000 shares
authorized, 5,871,002 shares issued and outstanding																																																587	587	587
stockholders' equity:
end of term liability, note payable																																																		132,500	106,000
common stock .0001 par value at march 31, 2013 and
december 31, 2012, respectively; 75,000,000 shares
property and equipment, at cost																																																			779,297
notes payable - related parties
note payable, net of debt discount																																																			3,773,524
preferred stock - 0.001 par value, 10,000,000 and 8,221,678 shares authorized, 0 and 8,221,678 shares issued and outstanding with a liquidation preference of 0 and 31,959,545 at december 31, 2012 and 2011, respectively
common stock - 0.0001 and 0.001 par value at december 31, 2012 and 2011, respectively; 75,000,000 and 6,500,000 shares authorized, 4,622,831 and 408,589 shares issued and outstanding at december 31, 2012 and 2011, respectively																																																			462
current assets
other assets
equity issuance costs
current liabilities
notes payable – related parties
preferred stock - 0.001 par value: 10,000,000 and 8,221,678 shares authorized, 0 and 8,221,678 shares issued and outstanding with a liquidation preference of 0 and 31,959,545 at september 30, 2012 and december 31, 2011, respectively
common stock - 0.0001 and 0.001 par value: 75,000,000 and 6,500,000 authorized, 4,654,303 and 408,589 shares issued and outstanding at september 30, 2012 and december 31, 2011, respectively																																																				465
preferred stock - 0.001 par value: 10,000,000 and 8,221,678 shares authorized, 0 and 8,221,678 shares issued and outstanding with a liquidation preference of 0 and 31,959,545 at june 30, 2012 and december 31, 2011, respectively
common stock - 0.001 par value: 75,000,000 and 6,500,000 authorized, 4,654,303 and 408,589 shares issued and outstanding at june 30, 2012 and december 31, 2011, respectively																																																					4,654
preferred stock - 0.001 par value: 10,000,000 and 8,221,678 shares authorized, 0 and 8,221,678 shares issued and outstanding with a liquidation preference of 0 and 31,959,545 at march 31, 2012 and december 31, 2011, respectively
common stock - 0.001 par value: 75,000,000 and 6,500,000 authorized, 4,654,303 and 408,589 shares issued and outstanding at march 31, 2012 and december 31, 2011, respectively																																																						4,654
preferred stock, .0001 par value; 10,000,000 shares authorized, none issued and outstanding
deficit accumulated during the development stage																																																							-145,230		-128,468	-123,468	-118,239		-106,024	-101,214	-96,888	-84,000	-80,180
preferred stock; .0001 par value, 10,000,000 shares authorized, none issued and outstanding
deficit accumulated during the development period																																																								-140,056				-113,596
liabilities and stockholders’ deficiency
stockholders’ deficiency
total stockholders’ deficiency																																																															-638

We provide you with 20 years of balance sheets for ADMA Biologics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ADMA Biologics. Explore the full financial landscape of ADMA Biologics stock with our expertly curated balance sheets.

The information provided in this report about ADMA Biologics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.